Roberts Laboratories Inc.
Records under this name other than patents Roberts Laboratories Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Roberts Laboratories Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,194,420 | 2-amino-5,6-dichloro-3,4-dihydroquinazoline, its method of making and using and pharmaceutical compositions thereof Formerly held Term ended Term ended Nov 30, 2019 · From the USPTO record | Term ended | Term ended Nov 30, 2019 | From the USPTO record |
| US 6,479,529 | Antioxidant stabilizer system for pharmaceutical formulations Formerly held Lapsed on the fee record Ended Nov 12, 2010 · From the USPTO record | Lapsed on the fee record | Ended Nov 12, 2010 | From the USPTO record |
| US 4,285,932 | Enzyme derivatives for use in the treatment of venous thrombosis Term ended Term ended no later than Aug 25, 2001 · Low confidence | Term ended | Term ended no later than Aug 25, 2001 | Low confidence |
| US 4,337,244 | Enzyme derivatives for use in the treatment of venous thrombosis Term ended Term ended no later than Jun 29, 2002 · Low confidence | Term ended | Term ended no later than Jun 29, 2002 | Low confidence |
| US 4,357,330 | Pharmaceutical compositions Term ended Term ended no later than Nov 2, 2002 · Low confidence | Term ended | Term ended no later than Nov 2, 2002 | Low confidence |
| US 4,808,405 | P-anisoyl streptokinase/plasminogen complex Term ended Term ended no later than Feb 28, 2009 · Low confidence | Term ended | Term ended no later than Feb 28, 2009 | Low confidence |
| US 5,202,435 | Process for the preparation of moricizine hydrochloride Term ended Term ended no later than Apr 13, 2013 · Low confidence | Term ended | Term ended no later than Apr 13, 2013 | Low confidence |
| US 5,334,384 | Process for purification of streptakinase using a reducing agent Term ended Term ended no later than Aug 2, 2014 · Low confidence | Term ended | Term ended no later than Aug 2, 2014 | Low confidence |
| US 5,801,245 | Process for the preparation of ethyl-N-(2,3 dichloro-6-nitrobenzyl) glycine Formerly held Term ended Term ended no later than Sep 1, 2018 · Low confidence | Term ended | Term ended no later than Sep 1, 2018 | Low confidence |
| US 5,962,488 | Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives Formerly held Term ended Term ended no later than Oct 5, 2019 · Low confidence | Term ended | Term ended no later than Oct 5, 2019 | Low confidence |